You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
魚躍醫療(002223.SZ)上修業績預告:半年度淨利潤預增100%-110%
格隆匯 07-07 17:02

格隆匯 7 月 7日丨魚躍醫療(002223.SZ)發佈2020年半年度業績預告修正公告,之前在2020年第一季度報告中預計公司2020年1-6月歸屬於上市公司股東的淨利潤約8億元-8.27億元,同比增長50%-55%。

修正後,預計2020年半年度歸屬於上市公司股東的淨利潤10.67億元-11.20億元,同比增長100%-110%。業績修正原因如下:

依託強力高效的研發、製造與供應鏈體系,公司在今年上半年完成了大量海內外抗疫類產品訂單的交付工作,其中無創呼吸機等呼吸類、紅外額温槍、血氧儀等檢測類與消毒感控類疫情防控產品出貨量增幅較大。經歷疫情考驗,公司品牌力與知名度進一步提升,有促進了院外產品業務的持續擴張,對院內產品的市場拓展也助益良多。

自二季度以來,公司常規市場銷售趨勢修復良好,其中血壓檢測類、血糖類等主要產品線上銷售已超去年同期水平。在“618”活動中,隨着公司各品類第三代旗艦新款的首次亮相,製氧機、電子血壓計、呼吸機、霧化器與輪椅等多種產品全網銷售領先。同時,得益於公司消毒感控產品在疫情一線的卓越表現與優秀的使用感受,越來越多的普通消費者在日常生活中選擇“潔芙柔”系列產品進行個人感控防護,其民品業務增長強勁,兼有抗疫類產品在二季度大量訂單完成並確認銷售的因素,公司2020年上半年整體業績狀況顯著優於原有預期,故對相關業績預告做出修正。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account